Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
$16.78
0.17 (1.02%)
TEVA Stock Quote Delayed 30 Minutes
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Hits 13-Year Low
Teva Pharmaceutical is a beckoning opportunity for contrarian investors, as there's blood in the streets for TEVA stock but it's not fatal.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
18.63B
PE Ratio
-11.57
EPS
-1.45
Volume (Avg. Vol.)
7.48M
Day's Range
$16.62 - $17.13
52-Week Range
$12.51 - $22.80
Dividend & Yield
N/A (N/A)
TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries Limited American Depositary Shares News
Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Before Q2 Earnings
Teva Pharmaceutical is shedding assets and beginning to get synergies from its M&A. TEVA stock looks like a compelling trade.
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back
Teva Pharmaceuticals' ugly rout in 2016, and an even uglier industry headwind, TEVA stock is a lot stronger than many give it credit for.
Why Cyberark Software Ltd (CYBR), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Wynn Resorts, Limited (WYNN) Are 3 of Today’s Worst Stocks
Teva Pharmaceutical (TEVA), Wynn Resorts (WYNN) and Cyberark Software (CYBR) shareholders couldn't wait for the trading week to end.
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Reach $40
With operational improvements ahead at Teva (TEVA), there is now less downside risk to TEVA stock over the next 18 months.
Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence
Valeant Pharmaceuticals (VRX) finds relief as John Paulson joins the board, but what can he really do to help VRX stock holders?
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Time to Go Contrarian?
Teva Pharmaceuticals (TEVA) has been beaten down to the point where the bears no longer want it, setting up a contrarian play in TEVA stock.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Nibble on Its Dividend and Wait
Teva Pharmaceutical (TEVA) is perhaps the poster child for what can go wrong with an investment. But TEVA stock is cheap and could double in price.
Is Teva Pharmaceutical Industries Ltd (ADR) Stock a Migraine Buy?
Teva's recent migraine drug data, while positive, didn't impress investors. What happened, and should you tussle with TEVA stock?
How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover
Teva Pharmaceutical desperately needs a new CEO - and a new strategy to boot - to stop the steady decline in TEVA stock.
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Gain 30%
Teva (TEVA) has been unfairly beat down, but its near-5% dividend yield makes TEVA stock worthwhile while waiting on the recovery.
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Going to $40
Teva Pharmaceutical (TEVA) offers good value, especially when combined with its 4.49% annual dividend yield. Here's how TEVA stock is heading to $40.
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Recover
TEVA stock has been slammed with poor news and fierce competition, but with a little luck, Teva Pharmaceuticals could be a big play in 2017.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Bounce Now
Teva Pharmaceutical's first-quarter earnings and reaffirmed guidance are good enough, and should at least drive a relief rally in TEVA stock.
Should You Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock? 3 Pros, 3 Cons
TEVA stock has had a terrible year. While the situation is still fraught with risk, however, the upside is starting to look compelling.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Has a Chance
Teva Pharmaceuticals (TEVA) has been on a downward spiral for the past year, but much of the bad news may already be baked into TEVA stock.
Teva Pharmaceutical (TEVA) Stock Can Capture 376% Returns
Teva Pharmaceutical is in deep value territory ahead of earnings. This play on TEVA stock is a great alternative to going long outright.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Has 25% Upside
TEVA stock can deliver 25% returns in the next 12 to 18 months on its way towards $40 per share. Here's what you need to know about Teva Pharmaceutical.
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Double
If TEVA stock wasn’t so darn low, I’d recommend investors run for the hills. But Teva Pharmaceuticals has some room to run higher.
